S&P 500   3,390.60 (+1.65%)
DOW   28,006.09 (+2.02%)
QQQ   280.57 (+1.67%)
AAPL   117.16 (+2.69%)
MSFT   211.91 (+2.24%)
FB   264.95 (+1.21%)
GOOGL   1,485.34 (+1.32%)
AMZN   3,197.77 (+1.68%)
TSLA   431.25 (+2.91%)
NVDA   544.20 (+2.87%)
BABA   292.89 (+5.76%)
CGC   14.49 (-0.07%)
GE   6.28 (+2.61%)
MU   47.80 (-5.74%)
AMD   82.68 (+1.11%)
T   28.64 (+1.20%)
F   6.70 (+1.52%)
ACB   4.68 (+0.00%)
GILD   63.40 (+2.09%)
NFLX   504.40 (+2.21%)
DIS   125.03 (-0.30%)
BA   167.99 (+2.68%)
BAC   24.29 (+2.19%)
S&P 500   3,390.60 (+1.65%)
DOW   28,006.09 (+2.02%)
QQQ   280.57 (+1.67%)
AAPL   117.16 (+2.69%)
MSFT   211.91 (+2.24%)
FB   264.95 (+1.21%)
GOOGL   1,485.34 (+1.32%)
AMZN   3,197.77 (+1.68%)
TSLA   431.25 (+2.91%)
NVDA   544.20 (+2.87%)
BABA   292.89 (+5.76%)
CGC   14.49 (-0.07%)
GE   6.28 (+2.61%)
MU   47.80 (-5.74%)
AMD   82.68 (+1.11%)
T   28.64 (+1.20%)
F   6.70 (+1.52%)
ACB   4.68 (+0.00%)
GILD   63.40 (+2.09%)
NFLX   504.40 (+2.21%)
DIS   125.03 (-0.30%)
BA   167.99 (+2.68%)
BAC   24.29 (+2.19%)
S&P 500   3,390.60 (+1.65%)
DOW   28,006.09 (+2.02%)
QQQ   280.57 (+1.67%)
AAPL   117.16 (+2.69%)
MSFT   211.91 (+2.24%)
FB   264.95 (+1.21%)
GOOGL   1,485.34 (+1.32%)
AMZN   3,197.77 (+1.68%)
TSLA   431.25 (+2.91%)
NVDA   544.20 (+2.87%)
BABA   292.89 (+5.76%)
CGC   14.49 (-0.07%)
GE   6.28 (+2.61%)
MU   47.80 (-5.74%)
AMD   82.68 (+1.11%)
T   28.64 (+1.20%)
F   6.70 (+1.52%)
ACB   4.68 (+0.00%)
GILD   63.40 (+2.09%)
NFLX   504.40 (+2.21%)
DIS   125.03 (-0.30%)
BA   167.99 (+2.68%)
BAC   24.29 (+2.19%)
S&P 500   3,390.60 (+1.65%)
DOW   28,006.09 (+2.02%)
QQQ   280.57 (+1.67%)
AAPL   117.16 (+2.69%)
MSFT   211.91 (+2.24%)
FB   264.95 (+1.21%)
GOOGL   1,485.34 (+1.32%)
AMZN   3,197.77 (+1.68%)
TSLA   431.25 (+2.91%)
NVDA   544.20 (+2.87%)
BABA   292.89 (+5.76%)
CGC   14.49 (-0.07%)
GE   6.28 (+2.61%)
MU   47.80 (-5.74%)
AMD   82.68 (+1.11%)
T   28.64 (+1.20%)
F   6.70 (+1.52%)
ACB   4.68 (+0.00%)
GILD   63.40 (+2.09%)
NFLX   504.40 (+2.21%)
DIS   125.03 (-0.30%)
BA   167.99 (+2.68%)
BAC   24.29 (+2.19%)
Log in
NYSEAMERICAN:MYO

Myomo Stock Forecast, Price & News

$4.46
-0.05 (-1.11 %)
(As of 09/30/2020 02:08 PM ET)
Add
Compare
Today's Range
$4.46
Now: $4.46
$4.56
50-Day Range N/A
52-Week Range
$2.82
Now: $4.46
$40.00
Volume192 shs
Average Volume719,621 shs
Market Capitalization$16.38 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis used for the purpose of supporting a patient's weak or deformed arm to enable and improve functional activities of daily living, ADLs, in the home and community. Its products are designed to help restore function in individuals with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals, and through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
Read More
Myomo logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.22 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:MYO
CUSIPN/A
Phone+1-617-9969058

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees45
Market Cap$16.38 million
Next Earnings Date11/10/2020 (Estimated)
OptionableNot Optionable
$4.46
-0.05 (-1.11 %)
(As of 09/30/2020 02:08 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MYO News and Ratings via Email

Sign-up to receive the latest news and ratings for MYO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Myomo (NYSEAMERICAN:MYO) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Myomo?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Myomo in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Myomo
.

When is Myomo's next earnings date?

Myomo is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Myomo
.

How were Myomo's earnings last quarter?

Myomo Inc (NYSEAMERICAN:MYO) posted its quarterly earnings results on Monday, August, 10th. The company reported ($1.12) earnings per share for the quarter, topping analysts' consensus estimates of ($1.31) by $0.19. The business had revenue of $0.86 million for the quarter, compared to analyst estimates of $0.60 million.
View Myomo's earnings history
.

What price target have analysts set for MYO?

4 brokerages have issued 12 month price targets for Myomo's stock. Their forecasts range from $8.00 to $15.00. On average, they expect Myomo's share price to reach $10.50 in the next twelve months. This suggests a possible upside of 130.3% from the stock's current price.
View analysts' price targets for Myomo
.

Are investors shorting Myomo?

Myomo saw a drop in short interest in the month of September. As of September 15th, there was short interest totaling 95,700 shares, a drop of 10.5% from the August 31st total of 106,900 shares. Based on an average trading volume of 1,110,000 shares, the short-interest ratio is presently 0.1 days. Currently, 3.1% of the company's stock are sold short.
View Myomo's Short Interest
.

Who are some of Myomo's key competitors?

What other stocks do shareholders of Myomo own?

Who are Myomo's key executives?

Myomo's management team includes the following people:
  • Mr. Paul R. Gudonis, Chairman, Pres & CEO (Age 64)
  • Mr. Jonathan Naft, VP & GM (Age 54)
  • Mr. David A. Henry, Chief Financial Officer (Age 58)
  • Mr. Clifford J. Conneighton, Chief Marketing Officer (Age 69)
  • Dr. Brandon Green DO, BOCP, Chief Medical Officer (Age 72)

What is Myomo's stock symbol?

Myomo trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MYO."

How do I buy shares of Myomo?

Shares of MYO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Myomo's stock price today?

One share of MYO stock can currently be purchased for approximately $4.56.

How big of a company is Myomo?

Myomo has a market capitalization of $16.74 million. Myomo employs 45 workers across the globe.

What is Myomo's official website?

The official website for Myomo is myomo.com.

How can I contact Myomo?

Myomo's mailing address is One Broadway, 14Th Floor, CAMBRIDGE, MA 02142, United States. The company can be reached via phone at +1-617-9969058.

This page was last updated on 9/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.